Share of tuberculosis patients with HIV in Georgia
Georgia: Share of tuberculosis patients with HIV was 2.9% in 2024. ◆ Volatile
Share of tuberculosis patients with HIV in Georgia, 2000–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in %.
Analysis
In 2024, share of tuberculosis patients with hiv in Georgia stood at 2.9%.
That represents a change of up 26.1% on the previous year and up 31.8% over ten years.
Over the whole period, share of tuberculosis patients with hiv in Georgia peaked at 3.0% in 2012 and was at its lowest, 0.1%, in 2000.
Georgia ranks 102nd of 179 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Share of tuberculosis patients with HIV in Georgia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.1% | — |
| 2001 | 0.1% | +36.4% |
| 2002 | 0.2% | +53.3% |
| 2003 | 0.4% | +60.9% |
| 2004 | 0.6% | +48.6% |
| 2005 | 0.8% | +41.8% |
| 2006 | 1.0% | +28.2% |
| 2007 | 1.9% | +90.0% |
| 2008 | 1.3% | -31.6% |
| 2009 | 2.0% | +53.8% |
| 2010 | 1.3% | -35.0% |
| 2011 | 2.7% | +107.7% |
| 2012 | 3.0% | +11.1% |
| 2013 | 2.0% | -33.3% |
| 2014 | 2.2% | +10.0% |
| 2015 | 2.8% | +27.3% |
| 2016 | 2.1% | -25.0% |
| 2017 | 1.8% | -14.3% |
| 2018 | 2.1% | +16.7% |
| 2019 | 1.8% | -14.3% |
| 2020 | 1.9% | +5.6% |
| 2021 | 3.0% | +57.9% |
| 2022 | 2.9% | -3.3% |
| 2023 | 2.3% | -20.7% |
| 2024 | 2.9% | +26.1% |
Georgia compared with similar countries
- Georgia's 2.9% is below the median for upper middle income countries, which is 5.8%, 50% of the median. (51 countries reporting)
- Georgia's 2.9% is above the median for Europe & Central Asia, which is 2.8%, 1.0× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.8% | 0.1% | 2.0% | 10 |
| 2010s | 2.2% | 1.3% | 3.0% | 10 |
| 2020s | 2.6% | 1.9% | 3.0% | 5 |
Countries ranked near Georgia
More health data for Georgia
- Un projection of annual infant deaths, annual growth rate -3.7 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0382 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,310 deaths per 1,000 people (2090)
- Number of infants who die before age 1 26 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.2207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.2812 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is share of tuberculosis patients with hiv in Georgia?
- Share of tuberculosis patients with hiv in Georgia was 2.9% in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest share of tuberculosis patients with hiv recorded in Georgia?
- The highest recorded value was 3.0% in 2012.
- What is the lowest share of tuberculosis patients with hiv recorded in Georgia?
- The lowest recorded value was 0.1% in 2000.
- How does Georgia rank for share of tuberculosis patients with hiv?
- Georgia ranks 102nd out of 179 countries with data for 2024.
- Is share of tuberculosis patients with hiv rising or falling in Georgia?
- Over the last ten years it is up 31.8%. The long-run trend across the full record is volatile.
- Where does this Georgia data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Share of tuberculosis patients with HIV. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The estimated share of people with tuberculosis who also have HIV.